ReviewFrontiers in endocrinology2021

Therapeutic Targeting of SGLT2: A New Era in the Treatment of Diabetes and Diabetic Kidney Disease.

James Shaffner et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.